These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3556279)

  • 1. Treatment with anti-T-lymphocyte antibodies prevents induction of insulitis in mice given multiple doses of streptozocin.
    Herold KC; Montag AG; Fitch FW
    Diabetes; 1987 Jul; 36(7):796-801. PubMed ID: 3556279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice.
    Koike T; Itoh Y; Ishii T; Ito I; Takabayashi K; Maruyama N; Tomioka H; Yoshida S
    Diabetes; 1987 Apr; 36(4):539-41. PubMed ID: 3102302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L3T4 and Lyt-2 T cells are both involved in the generation of low-dose streptozotocin-induced diabetes in mice.
    Kantwerk G; Cobbold S; Waldmann H; Kolb H
    Clin Exp Immunol; 1987 Dec; 70(3):585-92. PubMed ID: 2963718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-interleukin 2 receptor antibody attenuates low-dose streptozotocin-induced diabetes in mice.
    Hatamori N; Yokono K; Hayakawa M; Taki T; Ogawa W; Nagata M; Hari J; Shii K; Taniguchi H; Baba S
    Diabetologia; 1990 May; 33(5):266-71. PubMed ID: 2142923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of insulitis by adoptive transfer with L3T4+Lyt2- T-lymphocytes in T-lymphocyte-depleted NOD mice.
    Hanafusa T; Sugihara S; Fujino-Kurihara H; Miyagawa J; Miyazaki A; Yoshioka T; Yamada K; Nakajima H; Asakawa H; Kono N
    Diabetes; 1988 Feb; 37(2):204-8. PubMed ID: 3292315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of silica particles or anti-Lyt2 antibody prevents beta-cell destruction in NOD mice given cyclophosphamide.
    Charlton B; Bacelj A; Mandel TE
    Diabetes; 1988 Jul; 37(7):930-5. PubMed ID: 2838358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes induced with low doses of streptozotocin is mediated by V beta 8.2+ T-cells.
    Herold KC; Bloch TN; Vezys V; Sun Q
    Diabetes; 1995 Mar; 44(3):354-9. PubMed ID: 7883124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathymic transplantation of islet antigen affects CD8+ diabetogenic T-cells resulting in tolerance to autoimmune IDDM.
    Baumann EE; Buckingham F; Herold KC
    Diabetes; 1995 Aug; 44(8):871-7. PubMed ID: 7621990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helper-inducer T-lymphocytes mediate diabetes in EMC-infected BALB/c ByJ mice.
    Haynes MK; Huber SA; Craighead JE
    Diabetes; 1987 Jul; 36(7):877-81. PubMed ID: 2438180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of thymic immunity and insulitis in the development of streptozocin-induced diabetes in mice.
    Nakamura M; Nagafuchi S; Yamaguchi K; Takaki R
    Diabetes; 1984 Sep; 33(9):894-900. PubMed ID: 6236118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin attenuates low-dose streptozotocin-induced immune diabetes in mice and inhibits the beta-cell binding of T-splenocytes in vitro.
    Saï P; Pogu S; Ouary M
    Diabetologia; 1991 Apr; 34(4):212-7. PubMed ID: 2065856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of streptozocin-induced insulitis and diabetes with lobenzarit in CD-1 mice.
    Iwakiri R; Nagafuchi S
    Diabetes; 1989 May; 38(5):558-61. PubMed ID: 2653927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibody.
    Herold KC; Bluestone JA; Montag AG; Parihar A; Wiegner A; Gress RE; Hirsch R
    Diabetes; 1992 Mar; 41(3):385-91. PubMed ID: 1532369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice.
    Miller BJ; Appel MC; O'Neil JJ; Wicker LS
    J Immunol; 1988 Jan; 140(1):52-8. PubMed ID: 3275717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CD3 immunotoxin prevents low-dose STZ/interferon-induced autoimmune diabetes in mouse.
    Vallera DA; Carroll SF; Brief S; Blazar BR
    Diabetes; 1992 Apr; 41(4):457-64. PubMed ID: 1376702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression from insulitis to beta-cell destruction in NOD mouse requires L3T4+ T-lymphocytes.
    Charlton B; Mandel TE
    Diabetes; 1988 Aug; 37(8):1108-12. PubMed ID: 3292330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell-adherent splenocytes precede the onset of diabetes in low-dose streptozotocin-treated mice.
    Feve B; Segain JP; Charbonnel B; Sai P
    Diabetologia; 1990 Jan; 33(1):9-14. PubMed ID: 2137423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of immunosuppression on streptozotocin-induced diabetes in C57BL/KsJ mice.
    Leiter EH; Beamer WG; Shultz LD
    Diabetes; 1983 Feb; 32(2):148-55. PubMed ID: 6219026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of helper and/or cytotoxic T-lymphocyte depletion on low-dose streptozocin-induced diabetes in C57BL/6J mice.
    Dayer-Métroz MD; Kimoto M; Izui S; Vassalli P; Renold AE
    Diabetes; 1988 Aug; 37(8):1082-9. PubMed ID: 3260567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes induction by subdiabetogenic doses of streptozotocin in BALB/cBOM mice. Noninvolvement of host B-lymphocyte functions.
    Blue ML; Shin SI
    Diabetes; 1984 Feb; 33(2):105-10. PubMed ID: 6229438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.